Duro-K lead issue no cause for alarm

The TGA has advised that it has learned that one batch of Duro-K 600mg potassium chloride tablets exceed permitted lead levels Following testing to comply with the new regulatory guidelines that came into effect in December 2017, Novartis notified the TGA that Duro-K potassium chloride 600mg tablets and Slow-K potassium chloride 600mg tablets may exceed